VSHP Webinar 

Thursday, February 22, 2024 – 12:00pm-1:00 pm

Management of Cardiac Amyloidosis in the Inpatient and Future Therapeutic Landscape  

Speaker:

Seth Gillen, Pharm.D.

PGY1 Pharmacy Resident

Riverside Regional Medical Center

Objectives for Pharmacists

•       Recognize the pathophysiology and epidemiology of cardiac amyloidosis.

•       Compare the differences between AL and TTR cardiac amyloidosis treatment.

•       Apply the fundamentals of cardiac amyloidosis management to an inpatient.

•       Discuss the potential advancements in the treatment of cardiac amyloidosis.

Objectives for Pharmacy Technicians

•       Recognize the pathophysiology and epidemiology of cardiac amyloidosis.

•       List the differences between AL and TTR cardiac amyloidosis treatment.

•       List the potential advancements in the treatment of cardiac amyloidosis.

Accreditation:

Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education and has assigned 1.0 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.

ACPE UAN:  0108-0000-24-003-L01-P; 0108-0000-24-003-L01-T

Activity type: Knowledge-based

This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

Non-members will be charged $20.

To register:  https://us02web.zoom.us/webinar/register/WN_c6nGhRnDRwe-2UWYvRxjaA